Can antibiotics prevent preterm birth--the pro and con debate

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Maternal-Fetal Medicine

Background:

• Preterm birth is a significant concern with varied etiological factors.
• Previous studies on antibiotics for preventing preterm birth yielded inconsistent results due to methodological limitations.
• Abnormal genital tract flora is increasingly recognized as a key infectious contributor to preterm birth.

Purpose of the Study:

• To evaluate the efficacy of antibiotic treatment for abnormal genital tract flora in preventing preterm birth.
• To determine optimal timing and patient selection for antibiotic prophylaxis in pregnancy.

Main Methods:

• Analysis of studies with diverse diagnostic methods, antibiotic regimens, and outcome parameters.
• Inclusion of data from randomized double-blind placebo-controlled trials.
• Focus on women with abnormal genital tract flora, particularly in early pregnancy.

Main Results:

• Two randomized trials showed a 60% reduction in preterm birth with clindamycin in low-risk women.
• Abnormal flora in early pregnancy, even if transient, is associated with a high risk of adverse pregnancy outcomes.
• Early detection and treatment of abnormal flora are critical for preventing preterm birth.

Conclusions:

• Antibiotic prophylaxis is most effective when administered early in pregnancy to women with abnormal genital tract flora.
• The timing of antibiotic administration is critical, ideally before significant inflammation or tissue damage occurs.
• Targeting women with abnormal flora and a predisposition to inflammatory responses may enhance the success of prophylactic antibiotics.